Alnylam Pharmaceuticals, Inc.

CIBC Asset Management Inc ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

29,832

Value ($000)

11,863

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	11,863	0.0%	29,832	12/31/2025
2025 Q3	10/31/2025	2,507	0.0%	5,498	9/30/2025
2025 Q2	8/14/2025	1,780	0.0%	5,458	6/30/2025
2025 Q1	5/13/2025	1,464	0.0%	5,422	3/31/2025
2024 Q4	1/31/2025	1,208	0.0%	5,134	12/31/2024
2024 Q3	11/6/2024	1,233	0.0%	4,483	9/30/2024
2024 Q2	8/1/2024	1,033	0.0%	4,249	6/30/2024
2024 Q1	5/9/2024	601	0.0%	4,022	3/31/2024
2023 Q4	2/13/2024	768	0.0%	4,014	12/31/2023
2023 Q3	10/30/2023	765	0.0%	4,322	9/30/2023
2023 Q2	8/14/2023	797	0.0%	4,194	6/30/2023
2023 Q1	5/12/2023	840	0.0%	4,191	3/31/2023
2022 Q4	2/13/2023	976	0.0%	4,107	12/31/2022
2022 Q3	11/3/2022	1,062	0.0%	5,306	9/30/2022
2022 Q2	8/9/2022	772	0.0%	5,292	6/30/2022
2022 Q1	5/6/2022	880	0.0%	5,387	3/31/2022
2021 Q4	2/8/2022	909	0.0%	5,359	12/31/2021
2021 Q3	11/9/2021	902	0.0%	4,778	9/30/2021
2021 Q2	8/16/2021	738	0.0%	4,351	6/30/2021
2021 Q1	5/14/2021	613	0.0%	4,340	3/31/2021
2020 Q4	2/3/2021	543	0.0%	4,179	12/31/2020
2020 Q3	11/5/2020	608	0.0%	4,179	9/30/2020
2020 Q2	7/28/2020	604	0.0%	4,076	6/30/2020
2020 Q1	4/30/2020	444	0.0%	4,076	3/31/2020
2019 Q4	2/14/2020	550	0.0%	4,775	12/31/2019